The field of microfluidics uses microfabrication to create miniaturized devices to handle fluids. The field of microfluidics has four parents: molecular analysis, biodefence, molecular biology and microelectronics. Advances in microfluidics technology are revolutionizing molecular biology procedures for enzymatic analysis (glucose and lactate assays), DNA analysis (polymerase chain reaction and high-throughput sequencing), and proteomics. Microfluidics has numerous potential applications in health care, including drug discovery, formulation, and drug delivery, as well as life sciences research. An emerging application area for biochips is clinical pathology, especially the immediate point-of-care diagnosis of diseases. Much of the exploratory research in microfluidic
systems have been carried out in a polymer such as poly(dimethylsiloxane), or PDMS. Microfluidics can offer portable, cheap, single-use devices that replace centralized laboratory equipment in health care facilities and open new point-of-care diagnostic opportunities.
The global healthcare microfluidics market segmentation is based on product type (instruments, microfluidic chips, and cartridges and reagents), application (drug delivery, in vitro diagnostics, peripheral vascular diseases, pharmaceutical and biotech research, wound care management), material used (glass based, polymer based, silicon based), and end user (academics and research institutes, diagnostic labs, homecare, hospitals).
The global healthcare microfluidics market report provides market size (Revenue USD Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021). The global healthcare microfluidics market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global healthcare microfluidics market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.
Major players operating in the global healthcare microfluidics market and included in this report are Abbott Laboratories, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Danaher Corporation, F. Hoffmann-La Roche AG, IDEX Corporation, PerkinElmer, Inc., RainDance Technologies, Inc., and Thermo Fisher Scientific.